Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Preferred Stock Liabilities (2024 - 2025)

Historic Preferred Stock Liabilities for Kestra Medical Technologies (KMTS) over the last 2 years, with Q1 2025 value amounting to $280.5 million.

  • Kestra Medical Technologies' Preferred Stock Liabilities changed N/A to $280.5 million in Q1 2025 from the same period last year, while for Jan 2025 it was $280.5 million, marking a year-over-year change of. This contributed to the annual value of $177.1 million for FY2024, which is N/A changed from last year.
  • Per Kestra Medical Technologies' latest filing, its Preferred Stock Liabilities stood at $280.5 million for Q1 2025.
  • Kestra Medical Technologies' 5-year Preferred Stock Liabilities high stood at $280.5 million for Q1 2025, and its period low was $177.1 million during Q2 2024.